Literature DB >> 19555862

Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension.

Marius M Hoeper1, Joan Albert Barberà2, Richard N Channick3, Paul M Hassoun4, Irene M Lang5, Alessandra Manes6, Fernando J Martinez7, Robert Naeije8, Horst Olschewski9, Joanna Pepke-Zaba10, Margaret M Redfield11, Ivan M Robbins12, Rogério Souza13, Adam Torbicki14, Michael McGoon15.   

Abstract

The 4th World Symposium on Pulmonary Hypertension was the first international meeting to focus not only on pulmonary arterial hypertension (PAH) but also on the so-called non-PAH forms of pulmonary hypertension (PH). The term "non-PAH PH" summarizes those forms of PH that are found in groups 2 to 5 of the current classification of PH, that is, those forms associated with left heart disease, chronic lung disease, recurrent venous thromboembolism, and other diseases. Many of these forms of PH are much more common than PAH, but all of them have been less well studied, especially in terms of medical therapy. The working group on non-PAH PH focused mainly on 4 conditions: chronic obstructive lung disease, interstitial lung disease, chronic thromboembolic PH, and left heart disease. The medical literature regarding the role of PH in these diseases was reviewed, and recommendations regarding diagnosis and treatment of PH in these conditions are provided. Given the lack of robust clinical trials addressing PH in any of these conditions, it is important to conduct further studies to establish the role of medical therapy in non-PAH PH.

Entities:  

Mesh:

Year:  2009        PMID: 19555862     DOI: 10.1016/j.jacc.2009.04.008

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  82 in total

Review 1.  Noninvasive assessment of right ventricular function: will there be resurgence in radionuclide imaging techniques?

Authors:  Gautam V Ramani; Gagandeep Gurm; Vasken Dilsizian; Myung H Park
Journal:  Curr Cardiol Rep       Date:  2010-03       Impact factor: 2.931

Review 2.  Pulmonary hypertension with left-sided heart disease.

Authors:  Marco Guazzi; Ross Arena
Journal:  Nat Rev Cardiol       Date:  2010-10-05       Impact factor: 32.419

3.  Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment.

Authors:  Michal Schäfer; Cynthia Myers; R Dale Brown; Maria G Frid; Wei Tan; Kendall Hunter; Kurt R Stenmark
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

4.  Poor Subpleural Perfusion Predicts Failure After Balloon Pulmonary Angioplasty for Nonoperable Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Yu Taniguchi; Philippe Brenot; Xavier Jais; Carlos Garcia; Jason Weatherald; Olivier Planche; Elie Fadel; Marc Humbert; Gérald Simonneau
Journal:  Chest       Date:  2018-05-03       Impact factor: 9.410

Review 5.  Physiology of the pulmonary circulation and the right heart.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

Review 6.  Assessment of right ventricular function in pulmonary hypertension.

Authors:  Robert Naeije
Journal:  Curr Hypertens Rep       Date:  2015-05       Impact factor: 5.369

Review 7.  The role of imaging in pulmonary hypertension.

Authors:  Meenal Sharma; Andrew T Burns; Kelvin Yap; David L Prior
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

8.  Pulmonary arterial hypertension in the elderly-clinical characteristics and long-term survival.

Authors:  Avi Shimony; Benjamin D Fox; Jonathan Afilalo; Lawrence G Rudski; Andrew Hirsch; David Langleben
Journal:  Lung       Date:  2012-10-11       Impact factor: 2.584

9.  Preoperative echocardiographic-defined moderate-severe pulmonary hypertension predicts prolonged duration of mechanical ventilation following lung transplantation for patients with COPD.

Authors:  Jeremy P Wrobel; Bruce R Thompson; Gregory I Snell; Trevor J Williams
Journal:  Lung       Date:  2012-10-12       Impact factor: 2.584

Review 10.  Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension.

Authors:  Gautam V Ramani; Myung H Park
Journal:  Drug Des Devel Ther       Date:  2010-05-25       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.